{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:24:39Z","timestamp":1791545079529,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100012581","name":"The Macula Foundation Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.oret.2025.08.006","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T16:02:04Z","timestamp":1755100924000},"page":"165-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Rates of Endophthalmitis in Prefilled versus Nonprefilled Syringes for Intravitreal Injections"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1257-0476","authenticated-orcid":false,"given":"Charles","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"AbouKasm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Ersan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimesh A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Harry W.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas A.","family":"Yannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.08.006_bib1","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1111\/aos.14929","article-title":"Intravitreal anti-VEGF use in France: a cross-sectional and longitudinal Nationwide observational study","volume":"100","author":"Billioti de Gage","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib2","article-title":"Intravitreal therapy for diabetic macular edema: an update","volume":"2021","author":"Furino","year":"2021","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/IAE.0b013e3180307271","article-title":"Reducing the risk of endophthalmitis following intravitreal injections","volume":"27","author":"Scott","year":"2007","journal-title":"Retina"},{"key":"10.1016\/j.oret.2025.08.006_bib4","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.ophtha.2011.02.034","article-title":"Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents","volume":"118","author":"Shah","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.08.006_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0161-6420(01)00899-5","article-title":"Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update","volume":"109","author":"Ciulla","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.08.006_bib6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","article-title":"Prophylaxis of endophthalmitis with topical povidone-iodine","volume":"98","author":"Speaker","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.08.006_bib7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/24741264211028441","article-title":"Intravitreal injection therapy: current techniques and supplemental services","volume":"5","author":"Lam","year":"2021","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.oret.2025.08.006_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00417-015-3035-x","article-title":"The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection","volume":"254","author":"Storey","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2147\/OPTH.S169044","article-title":"Prefilled syringes for intravitreal drug delivery","volume":"13","author":"Sassalos","year":"2019","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib10","article-title":"Prefilled syringes for intravitreal injection reduce preparation time","volume":"63","author":"Subhi","year":"2016","journal-title":"Dan Med J"},{"key":"10.1016\/j.oret.2025.08.006_bib11","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s40123-024-01002-0","article-title":"Clinical outcomes and experiences with prefilled syringes versus vials for intravitreal administration of anti-VEGF treatments: a systematic review","volume":"13","author":"Uzzan","year":"2024","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.oret.2025.08.006_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14712598.2025.2482663","article-title":"Aflibercept biosimilars \u2013 so near, yet so far","volume":"25","author":"Sharma","year":"2025","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.oret.2025.08.006_bib13","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1056\/NEJMc1105759","article-title":"Safe preparation and administration of intravitreal bevacizumab injections","volume":"365","author":"Frost","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oret.2025.08.006_bib14","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s41433-025-03765-7","article-title":"Early intraocular pressure dynamics following aflibercept 8 mg versus aflibercept 2 mg: a propensity score-matched analysis","volume":"39","author":"Sarao","year":"2025","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2025.08.006_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamaophthalmol.2014.3591","article-title":"Evaluation of compounded bevacizumab prepared for intravitreal injection","volume":"133","author":"Yannuzzi","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/jamaophthalmol.2018.3939","article-title":"Association of acute endophthalmitis with intravitreal injections of corticosteroids or anti-vascular growth factor agents in a nationwide study in France","volume":"136","author":"Baudin","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib17","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/24741264231159011","article-title":"Reduced incidence of intravitreal injection-related endophthalmitis with prefilled syringes","volume":"7","author":"Feng","year":"2023","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.oret.2025.08.006_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000518236","article-title":"The effect of syringe-filling technique on the risk for endophthalmitis after intravitreal injection of anti-VEGF agents","volume":"245","author":"Finkelstein","year":"2022","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.oret.2025.08.006_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/24741264231191339","article-title":"Impact of prefilled syringes and masking on postintravitreal injection endophthalmitis","volume":"7","author":"Louis","year":"2023","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.oret.2025.08.006_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ajo.2018.11.023","article-title":"The impact of prefilled syringes on endophthalmitis following intravitreal injection of ranibizumab","volume":"199","author":"Storey","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib21","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1038\/s41598-019-46154-3","article-title":"Physical activity participation and the risk of chronic diseases among South Asian adults: a systematic review and meta-analysis","volume":"9","author":"Paudel","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2025.08.006_bib22","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.18632\/oncotarget.12885","article-title":"The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review","volume":"8","author":"Vuong","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.oret.2025.08.006_bib23","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.oret.2025.08.006_bib24","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.oret.2025.08.006_bib25","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2019"},{"key":"10.1016\/j.oret.2025.08.006_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/09273948.2020.1820530","article-title":"Does pharmaceutical compounding of vascular endothelial growth factor inhibitors for intravitreal use alter the risk of post-injection endophthalmitis?","volume":"30","author":"Blom","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.oret.2025.08.006_bib27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3928\/23258160-20210528-03","article-title":"Rates of suspected endophthalmitis following intravitreal injections in clinical practices in the United States","volume":"52","author":"Dhoot","year":"2021","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2025.08.006_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s10792-022-02489-x","article-title":"Incidence and visual outcomes of acute endophthalmitis post intravitreal injection of anti-vascular endothelial growth factors in a single referral center","volume":"43","author":"Gonzalez-Gonzalez","year":"2023","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib29","first-page":"559","article-title":"Incidence of endophthalmitis after intravitreal injections: risk factors, microbiology profile, and clinical outcomes","volume":"26","author":"Mishra","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.oret.2025.08.006_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-79377-w","article-title":"Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics","volume":"10","author":"Morioka","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2025.08.006_bib31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.oret.2023.12.004","article-title":"Endophthalmitis after anti-VEGF intravitreal injections with aqueous chlorhexidine versus povidone-iodine as ocular antiseptics","volume":"8","author":"Ton","year":"2024","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.08.006_bib32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0975-7406.154424","article-title":"Good manufacturing practices for medicinal products for human use","volume":"7","author":"Gouveia","year":"2015","journal-title":"J Pharm Bioallied Sci"},{"key":"10.1016\/j.oret.2025.08.006_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jamaophthalmol.2024.2749","article-title":"Endophthalmitis rates and types of treatments after intraocular procedures","volume":"142","author":"VanderBeek","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib34","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.oret.2025.03.002","article-title":"Intraocular inflammation after aflibercept prefilled syringe and vial injections","volume":"9","author":"Brown","year":"2025","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.08.006_bib35","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41433-021-01897-0","article-title":"Cohort studies investigating the effects of exposures: key principles that impact the credibility of the results","volume":"36","author":"Miroshnychenko","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2025.08.006_bib36","article-title":"Bacterial contamination of single and multiple-dose parenteral injection vials after opening and antibiotic susceptibility of isolates at Jimma Medical Center, Jimma, Southwest Ethiopia","volume":"5","author":"Tabor","year":"2023","journal-title":"Infect Prev Pract"},{"key":"10.1016\/j.oret.2025.08.006_bib37","article-title":"Injection procedures for intravitreal medications","volume":"2","author":"Appold","year":"2013","journal-title":"Ophthalmic Prof"},{"key":"10.1016\/j.oret.2025.08.006_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40942-021-00307-7","article-title":"Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review","volume":"7","author":"Anderson","year":"2021","journal-title":"Int J Retina Vitreous"},{"key":"10.1016\/j.oret.2025.08.006_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaophthalmol.2024.0530","article-title":"Severe intraocular inflammation following intravitreal faricimab","volume":"142","author":"Thangamathesvaran","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib40","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41598-018-37502-w","article-title":"New insights into culture negative endophthalmitis by unbiased next generation sequencing","volume":"9","author":"Deshmukh","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2025.08.006_bib41","article-title":"Causative microorganisms of infectious endophthalmitis: a 5-year retrospective study","volume":"2016","author":"Duan","year":"2016","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4103\/jomfp.JOMFP_304_18","article-title":"Oral microbiome: unveiling the fundamentals","volume":"23","author":"Deo","year":"2019","journal-title":"J Oral Maxillofac Pathol"},{"key":"10.1016\/j.oret.2025.08.006_bib43","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ajo.2013.12.026","article-title":"Endophthalmitis caused by streptococcal species: clinical settings, microbiology, management, and outcomes","volume":"157","author":"Kuriyan","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.08.006_bib44","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3928\/23258160-20140306-08","article-title":"Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents","volume":"45","author":"Fileta","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2025.08.006_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.oret.2020.06.028","article-title":"Endophthalmitis after cataract surgery: changes in management based on microbiologic cultures","volume":"5","author":"Patel","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2025.08.006_bib46","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41433-023-02698-3","article-title":"Biosimilar anti-VEGF- is prefilled syringe (PFS) a challenge?","volume":"38","author":"Sharma","year":"2024","journal-title":"Eye"},{"key":"10.1016\/j.oret.2025.08.006_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2024.1486318","article-title":"US regulatory compliance for medical combination products: an overview","volume":"6","author":"Singh","year":"2024","journal-title":"Front Med Technol"},{"key":"10.1016\/j.oret.2025.08.006_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-publhealth-051920-114020","article-title":"Methods to address confounding and other biases in meta-analyses: review and recommendations","volume":"43","author":"Mathur","year":"2022","journal-title":"Annu Rev Public Health"},{"issue":"suppl 2","key":"10.1016\/j.oret.2025.08.006_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12919-023-00285-8","article-title":"Rethinking the pros and cons of randomized controlled trials and observational studies in the era of big data and advanced methods: a panel discussion","volume":"18","author":"Fernainy","year":"2024","journal-title":"BMC Proc"},{"key":"10.1016\/j.oret.2025.08.006_bib50","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.6370","article-title":"Language bias among Chinese-sponsored randomized clinical trials in systematic reviews and meta-analyses-can anything be done?","volume":"3","author":"Mao","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.oret.2025.08.006_bib51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1017\/S0266462312000086","article-title":"The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies","volume":"28","author":"Morrison","year":"2012","journal-title":"Int J Technol Assess Health Care"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025003641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025003641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:29:05Z","timestamp":1779866945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025003641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2468653025003641"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.08.006","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rates of Endophthalmitis in Prefilled versus Nonprefilled Syringes for Intravitreal Injections","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}